Literature DB >> 18670240

Noninferiority and lopinavir/ritonavir monotherapy trials.

Federico Pulido, José R Arribas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18670240     DOI： 10.1097/QAD.0b013e32830a98ac

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

Review 1.  Monitoring antiretroviral therapy in resource-limited settings: balancing clinical care, technology, and human resources.

Authors:  Mina C Hosseinipour; Mauro Schechter
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

2.  Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial.

Authors:  Nicholas I Paton; Wolfgang Stöhr; Alejandro Arenas-Pinto; Martin Fisher; Ian Williams; Margaret Johnson; Chloe Orkin; Fabian Chen; Vincent Lee; Alan Winston; Mark Gompels; Julie Fox; Karen Scott; David T Dunn
Journal:  Lancet HIV       Date:  2015-09-14       Impact factor: 12.767

3.  Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks.

Authors:  Sidonie Lambert-Niclot; Philippe Flandre; Marc-Antoine Valantin; Cathia Soulie; Slim Fourati; Marc Wirden; Sophie Sayon; Sophie Pakianather; Laurence Bocket; Bernard Masquelier; Georges Dos Santos; Christine Katlama; Vincent Calvez; Anne-Genevieve Marcelin
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.